CME Group Inc. $CME Shares Newly Bought by Provenance Wealth Advisors LLC

Provenance Wealth Advisors LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,718 shares of the financial services provider’s stock, valued at approximately $450,000.

A number of other hedge funds and other institutional investors have also modified their holdings of CME. Whipplewood Advisors LLC boosted its holdings in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the last quarter. First Community Trust NA acquired a new stake in CME Group during the 3rd quarter valued at approximately $26,000. North Point Portfolio Managers Corp OH acquired a new stake in CME Group during the 3rd quarter valued at approximately $26,000. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in CME Group during the 2nd quarter worth approximately $28,000. Finally, Main Street Group LTD purchased a new stake in CME Group during the 1st quarter worth approximately $32,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Down 0.3%

NASDAQ:CME opened at $307.24 on Friday. The company has a market capitalization of $109.97 billion, a price-to-earnings ratio of 25.20, a price-to-earnings-growth ratio of 3.76 and a beta of 0.15. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The stock has a 50-day simple moving average of $282.60 and a 200 day simple moving average of $280.66. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.71 billion. During the same period in the previous year, the company earned $2.68 earnings per share. CME Group’s quarterly revenue was up 10.6% on a year-over-year basis. Sell-side analysts predict that CME Group Inc. will post 12.34 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be given a $1.30 dividend. The ex-dividend date is Friday, December 11th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is presently 42.66%.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 293 shares of CME Group stock in a transaction that occurred on Friday, September 25th. The shares were purchased at an average cost of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the purchase, the director directly owned 263,289 shares of the company’s stock, valued at $70,761,551.64. This trade represents a 0.11% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Howard J. Siegel sold 2,000 shares of CME Group stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $303.00, for a total transaction of $606,000.00. Following the completion of the transaction, the director directly owned 19,873 shares of the company’s stock, valued at approximately $6,021,519. This represents a 9.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 32,979 shares of company stock worth $9,552,762. Corporate insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on CME. Bank of America upped their target price on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday, July 23rd. TD Cowen increased their target price on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a research note on Monday, October 5th. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $286.00 to $270.00 in a research report on Wednesday, August 19th. Morgan Stanley lifted their price target on shares of CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a research note on Thursday, October 22nd. Finally, Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Saturday, October 31st. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $314.44.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.